REGENXBIO Inc.
RGNX institutional ownership changes in Q2 2026: 56 institutions opened or added positions, 51 trimmed or exited. RGNX (REGENXBIO Inc.) is held by 99 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($76.6M), State Street Corp. ($35.6M), JPMorgan Chase & Co. ($26.2M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Nov 3, 2026 · Activists Oct 13, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 6.4M(+10.6%) | $76.6M | 0.0% | -25.41% | 33 | |
Increased | 3M(+8.8%) | $35.6M | 0.0% | -56.15% | 32 | |
Decreased | 2.2M(-36.4%) | $26.2M | 0.0% | -17.82% | 0 | |
Increased | 2.1M(+5.0%) | $25.2M | 0.0% | -10.78% | 30 | |
Decreased | 2M(-5.5%) | $23.4M | 0.0% | -28.02% | 0 | |
Decreased | 1.4M(-22.7%) | $17M | 0.0% | -42.58% | 0 | |
Increased | 1.4M(+31.1%) | $16.5M | 0.0% | -18.27% | 36 | |
Increased | 1.4M(+33.0%) | $16.2M | 0.0% | -17.73% | 36 | |
New | 1.3M | $15.4M | 0.0% | -36.31% | 39 | |
Increased | 1.2M(+9.1%) | $14.9M | 0.0% | -73.75% | 31 | |
Increased | 740,026(+27.1%) | $8.9M | 0.0% | -22.70% | 34 | |
Decreased | 731,586(-27.6%) | $8.8M | 0.0% | -70.83% | 0 | |
Increased | 712,814(+149.2%) | $8.5M | 0.0% | -31.34% | 44 | |
Increased | 669,808(+20.7%) | $8M | 0.0% | -18.00% | 33 | |
New | 669,023 | $8M | 0.0% | -36.31% | 38 | |
Increased | 560,727(+42.8%) | $6.7M | 0.0% | -36.54% | 37 | |
Increased | 518,545(+59.6%) | $6.2M | 0.0% | -29.64% | 39 | |
Increased | 480,762(+68.6%) | $5.8M | 0.0% | -34.45% | 40 | |
Increased | 421,839(+7.2%) | $5.1M | 0.0% | -79.97% | 29 | |
Increased | 396,450(+1.5%) | $4.7M | 0.0% | -73.80% | 27 |
Showing 1-20 of 116
| Insider | Trade | Traded |
|---|---|---|
| Christmas Patrick J. | Vest 35K sh | |
| PAKOLA STEVE | Vest 35K sh | |
| Chan Mitchell | Vest 24K sh | |
| Malzahn Craig | Vest 28K sh | |
| Chan Mitchell | Tax 5K sh | |
| Malzahn Craig | Tax 234 sh | |
| Ciongoli Gregory Austin | Buy $500K | |
| Ciongoli Gregory Austin | Buy $450K | |
| Ciongoli Gregory Austin | Vest 15K sh | |
| Christmas Patrick J. | Tax 5K sh |
| Filer | Stake | Filed |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.3% | |
| JPMORGAN CHASE & CO | 4.4% | |
| STATE STREET CORPORATION | 5.3% | |
| The Vanguard Group | 0.0% | |
| BlackRock Portfolio Management LLC | 4.1% | |
| Redmile Group, LLC | 9.9% | |
| BlackRock, Inc. | 7.3% |
RGNXREGENXBIO Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about RGNX
Who owns RGNX?
99 institutional investors held RGNX on June 30, 2026, led by BlackRock, Inc. ($76.6M), State Street Corp. ($35.6M) and JPMorgan Chase & Co. ($26.2M).
How many hedge funds hold RGNX?
99 institutional investors reported RGNX in their 13F filings for the quarter ended June 30, 2026, $410.4M in all. 5 of them are rated Elite.
Are institutions buying or selling RGNX?
Buying, on balance. In Q2 2026, 56 institutions opened or added to positions in RGNX and 51 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer